La adquisición de vacunas contra la COVID-19 por Colombia: entre la confidencialidad y la falta de transparencia

Translated title of the contribution: The acquisition of vaccines against COVID-19 by Colombia: between confidentiality and lack of transparency

Gressy Kareny Rojas Cardona, David Mendieta

Research output: Contribution to journalArticlepeer-review

Abstract

Through an interpretation method based on the documentary review, the article criticizes the impossibility of carrying out timely surveillance of the negotiation process of the Colombian Government with pharmaceutical companies to acquire COVID-19 vaccines, thereby It gave priority to confidentiality as a free market prerogative over the principle of transparency as a state authority through the application of timely and adequate surveillance. First, an analysis is made of the decrees that grant extraordinary powers to the President of the Republic and the jurisprudential provisions of the high courts. Then, the normative foundation of the principle of transparency is proposed as the guiding principle of state contracting. There is also a contrast between the possibility of imposing confidentiality clauses, typical of private contracting, with the requirement to exercise vigilance as a guarantee of transparency in negotiations involving public finances. Finally, by highlighting the tension between the free market and fundamental rights, a reflection is made regarding the deficit in safeguarding the right to health due to the lack of timely surveillance that, because the principle of transparency is subordinated to confidentiality, it leaves open the possibility of a crisis of legitimacy, credibility and trust in the State.

Translated title of the contributionThe acquisition of vaccines against COVID-19 by Colombia: between confidentiality and lack of transparency
Original languageSpanish
Pages (from-to)284-310
Number of pages27
JournalRevista Brasileira de Politicas Publicas
Volume11
Issue number3
DOIs
StatePublished - Dec 2021

Fingerprint

Dive into the research topics of 'The acquisition of vaccines against COVID-19 by Colombia: between confidentiality and lack of transparency'. Together they form a unique fingerprint.

Cite this